Blujepa
Gepotidacin · GlaxoSmithKline LLC
CANCER MEDICINE · PRESCRIPTION ONLY (USA)Blujepa ingredients
| Active ingredient | Strength |
|---|---|
| Gepotidacin Mesylate | 750 mg/1 |
What Blujepa is used for
Blujepa is a cancer medicine (triazaacenaphthylene bacterial type ii topoisomerase inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Blujepa
- Generic name
- Gepotidacin
- Made by
- GlaxoSmithKline LLC
- Forms
- Tablet, Film Coated
- Given
- Oral
- Drug class
- Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor
- FDA approval
- New drug application (NDA) NDA218230
- On the US market since
- 2025
Official information
- Blujepa prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Gepotidacin)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Blujepa?
Blujepa (Gepotidacin) is a cancer medicine made by GlaxoSmithKline LLC, approved by the US FDA.
What are the ingredients of Blujepa?
Blujepa contains Gepotidacin Mesylate (750 mg/1).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA